Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Egg yolk phospholipids enriched with 1-O-octadecyl-2-oleoyl-sn-glycero-3-phospho-(N-palmitoyl) ethanolamine inhibit development of experimentally induced tumours

V. Karafiát, P. Veselý, M. Dvořák

. 2014 ; 60 (5) : 220-227.

Language English Country Czech Republic

Document type Journal Article, Research Support, Non-U.S. Gov't

Dietary phospholipids (PLs) and their derivatives have proved active in suppression of various health problems and conditions including cancer. In this work we compared the effect of dietary phospholipids from hen egg yolk enriched with N-acyl ether-phosphatidyl ethanolamine (NAEPE) termed bioactive phospholipids (BAP+ preparation) with PLs lacking NAEPE (BAP- preparation) on the growth of transformed cells in vitro and on the promotion and progression of experimental tumours in vivo. For the in vivo experiments we used the chicken model in which liver, lung, and kidney tumours arose via natural selection from single cells initiated by experimentally introduced somatic mutations caused by insertional mutagenesis. Mutagenized animals were fed BAP+ or BAP- diet in various regimens. We observed that BAP+ at low concentrations killed cells of various tumour cell lines in culture but did not compromise viability of non-transformed cells. Oral administration of the BAP+ preparation efficiently reduced progression of all tumour types. However, it did not significantly reduce the number of already initiated tumours and their growth when BAP+ was discontinued. Our data suggest that NAEPE combined with hen egg PLs significantly interferes with tumour progression, possibly through the inhibition of tumour cell viability.

000      
00000naa a2200000 a 4500
001      
bmc15040035
003      
CZ-PrNML
005      
20160114083131.0
007      
ta
008      
151230s2014 xr ad f 000 0|eng||
009      
AR
035    __
$a (PubMed)25863039
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Karafiát, Vít $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, v. v. i., Prague, Czech Republic $7 xx0127844
245    10
$a Egg yolk phospholipids enriched with 1-O-octadecyl-2-oleoyl-sn-glycero-3-phospho-(N-palmitoyl) ethanolamine inhibit development of experimentally induced tumours / $c V. Karafiát, P. Veselý, M. Dvořák
520    9_
$a Dietary phospholipids (PLs) and their derivatives have proved active in suppression of various health problems and conditions including cancer. In this work we compared the effect of dietary phospholipids from hen egg yolk enriched with N-acyl ether-phosphatidyl ethanolamine (NAEPE) termed bioactive phospholipids (BAP+ preparation) with PLs lacking NAEPE (BAP- preparation) on the growth of transformed cells in vitro and on the promotion and progression of experimental tumours in vivo. For the in vivo experiments we used the chicken model in which liver, lung, and kidney tumours arose via natural selection from single cells initiated by experimentally introduced somatic mutations caused by insertional mutagenesis. Mutagenized animals were fed BAP+ or BAP- diet in various regimens. We observed that BAP+ at low concentrations killed cells of various tumour cell lines in culture but did not compromise viability of non-transformed cells. Oral administration of the BAP+ preparation efficiently reduced progression of all tumour types. However, it did not significantly reduce the number of already initiated tumours and their growth when BAP+ was discontinued. Our data suggest that NAEPE combined with hen egg PLs significantly interferes with tumour progression, possibly through the inhibition of tumour cell viability.
650    _2
$a aplikace orální $7 D000284
650    _2
$a zvířata $7 D000818
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a proliferace buněk $x účinky léků $7 D049109
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a kultivované buňky $7 D002478
650    _2
$a kuřecí embryo $7 D002642
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a vaječný žloutek $x chemie $7 D004530
650    _2
$a ethanolaminy $x chemie $x farmakologie $7 D004983
650    _2
$a nádory $x farmakoterapie $x patofyziologie $7 D009369
650    _2
$a fosfolipidy $x aplikace a dávkování $x chemie $x farmakologie $7 D010743
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Veselý, Pavel $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, v. v. i., Prague, Czech Republic $7 xx0110363
700    1_
$a Dvořák, Michal $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, v. v. i., Prague, Czech Republic $7 xx0061505
773    0_
$w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 60, č. 5 (2014), s. 220-227
856    41
$u https://fb.cuni.cz/file/5755/fb2014a0042.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 970 $c 89 $y 4 $z 0
990    __
$a 20151230 $b ABA008
991    __
$a 20160112104610 $b ABA008
999    __
$a ok $b bmc $g 1103851 $s 923262
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 60 $c 5 $d 220-227 $i 0015-5500 $m Folia biologica (Praha) $n Folia biol. (Praha) $x MED00011004
LZP    __
$b NLK118 $a Pubmed-20151230

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...